MiNK Therapeutics, Inc. (INKT)
11.90
+0.45
(+3.93%)
USD |
NASDAQ |
Sep 09, 15:48
MiNK Therapeutics Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | -0.364 |
| September 30, 2025 | -0.4237 |
| June 30, 2025 | -0.2186 |
| March 31, 2025 | -0.2348 |
| December 31, 2024 | -0.2514 |
| September 30, 2024 | -0.2627 |
| June 30, 2024 | -0.2658 |
| March 31, 2024 | -0.2075 |
| December 31, 2023 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.8551 |
| June 30, 2021 | -0.8314 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 9.615M |
| Total Liabilities (Quarterly) | 23.64M |
| Shareholders Equity (Quarterly) | -14.03M |
| Current Ratio | 1.228 |
| Net Debt Paydown Yield | 1.72% |